Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 2091390

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 2091390

Intussusception Market Size, Share, and Growth Analysis, By Type (Idiopathic Intussusception, Secondary Intussusception), By Treatment (Enema Reduction, Surgery), By Diagnosis, By End User, By Region - Industry Forecast 2026-2033

PUBLISHED:
PAGES: 157 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Global Intussusception Market size was valued at USD 4.44 Billion in 2024 and is poised to grow from USD 4.68 Billion in 2025 to USD 7.07 Billion by 2033, growing at a CAGR of 5.3% during the forecast period (2026-2033).

The global intussusception market is centered on innovative products and services for diagnosing, managing, and treating intussusception, a condition predominantly affecting infants. The urgency for effective interventions stems from the potential for serious complications, driving market growth. Key factors propelling this expansion include the increasing use of minimally invasive reduction techniques such as ultrasound-guided pneumatic and hydrostatic enemas, which have largely replaced traditional surgical methods. Additionally, rising pediatric hospital admissions and growing awareness among clinicians contribute to market dynamics, notably seen through the adoption of air-contrast enema kits in regions like Southeast Asia and Latin America. The incorporation of advanced imaging technology and telemedicine enhances diagnostic access, particularly in underserved areas, while partnerships in sub-Saharan Africa further boost demand, positioning manufacturers at the forefront of the evolving market landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Intussusception market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Intussusception Market Segments Analysis

Global intussusception market is segmented by type, treatment, diagnosis, end user and region. Based on type, the market is segmented into Idiopathic Intussusception and Secondary Intussusception. Based on treatment, the market is segmented into Enema Reduction, Surgery and Other Treatments. Based on diagnosis, the market is segmented into Ultrasound, X-Ray, CT Scan and Barium Enema. Based on end user, the market is segmented into Hospitals, Specialty Clinics and Diagnostic Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Intussusception Market

The growing preference for minimally invasive procedures is significantly boosting the demand for innovative solutions in intussusception management. Surgeons are increasingly drawn to techniques that minimize operational trauma and enhance patient recovery times. This trend has sparked advancements in the development of specialized endoscopic instruments and imaging technologies designed for the detection and treatment of intussusception without the necessity of large incisions. As clinicians appreciate the precision afforded by these interventions, healthcare facilities are more likely to invest in cutting-edge equipment, leading to an expansion of the market for associated products and services. This investment momentum is further supported by favorable clinical outcomes and heightened surgeon confidence in these emerging technologies.

Restraints in the Global Intussusception Market

The global intussusception market faces significant limitations due to the high costs associated with advanced diagnostic equipment, which hinders its adoption in low-resource healthcare environments. Many healthcare facilities prioritize essential services, often overlooking the expensive imaging technologies necessary for accurate identification of intussusception. Budget constraints lead administrators to postpone the acquisition of such technologies, resulting in a reliance on traditional methods that lack precision and can impede timely treatment. Consequently, manufacturers experience lower sales in regions where financial challenges are severe, leading to uneven market penetration. This financial hurdle also stifles investments in research and development, thereby slowing technological advancements.

Market Trends of the Global Intussusception Market

The Global Intussusception market is witnessing a significant trend towards the adoption of innovative bioabsorbable devices, which are increasingly favored by clinicians for their safety and efficacy. With manufacturers accelerating the development of bioabsorbable stents and catheters that dissolve naturally post-treatment, the demand for these solutions is surging, particularly in pediatric and minimally invasive procedures. This trend is fueled by a growing body of evidence supporting their effectiveness, reduced complication rates, and enhanced recovery experiences for patients. Additionally, strategic collaborations between device developers and academic researchers are enhancing the credibility and integration of absorbable technologies, cementing their role as a transformative force in the treatment of intussusception.

Product Code: SQMIG35I3170

Table of Contents

Introduction

  • Objectives of the Study
  • Market Definition & Scope

Research Methodology

  • Research Process
  • Secondary & Primary Data Methods
  • Market Size Estimation Methods

Executive Summary

  • Global Market Outlook
  • Key Market Highlights
  • Segmental Overview
  • Competition Overview

Market Dynamics & Outlook

  • Macro-Economic Indicators
  • Drivers & Opportunities
  • Restraints & Challenges
  • Supply Side Trends
  • Demand Side Trends
  • Porters Analysis & Impact
    • Competitive Rivalry
    • Threat of Substitute
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factors
  • Market Impacting Factors
  • Top Investment Pockets
  • Ecosystem Mapping
  • Market Attractiveness Index 2025
  • PESTEL Analysis
  • Regulatory Landscape

Global Intussusception Market Size by Type & CAGR (2026-2033)

  • Market Overview
  • Idiopathic Intussusception
  • Secondary Intussusception

Global Intussusception Market Size by Treatment & CAGR (2026-2033)

  • Market Overview
  • Enema Reduction
    • Air Enema
    • Barium Enema
    • Water-Soluble Contrast Enema
  • Surgery
    • Laparoscopic Surgery
    • Open Surgery
  • Other Treatments

Global Intussusception Market Size by Diagnosis & CAGR (2026-2033)

  • Market Overview
  • Ultrasound
  • X-Ray
  • CT Scan
  • Barium Enema

Global Intussusception Market Size by End User & CAGR (2026-2033)

  • Market Overview
  • Hospitals
  • Specialty Clinics
  • Diagnostic Centers

Global Intussusception Market Size & CAGR (2026-2033)

  • North America (Type, Treatment, Diagnosis, End User)
    • US
    • Canada
  • Europe (Type, Treatment, Diagnosis, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Type, Treatment, Diagnosis, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Type, Treatment, Diagnosis, End User)
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Type, Treatment, Diagnosis, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Pfizer Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck & Co. Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bayer AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Novartis AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bristol-Myers Squibb Company
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sanofi S.A.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GlaxoSmithKline PLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Stryker Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Olympus Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GE HealthCare Technologies Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Steris PLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cook Medical LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CONMED Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Karl Storz SE & Co. KG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fujifilm Healthcare Solutions
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Richard Wolf GmbH
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Janssen Pharmaceuticals Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • EndoChoice Holdings Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!